Tonyali, O. Et Al. 2016. Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab. BREAST , vol.25 , 22-26.

Tonyali, O., Coskun, U., Yuksel, S., İNANÇ, M., Bal, O., Akman, T., ... Yazilitas, D.(2016). Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab. BREAST , vol.25, 22-26.

Tonyali, Onder Et Al. "Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab," BREAST , vol.25, 22-26, 2016

Tonyali, Onder Et Al. "Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab." BREAST , vol.25, pp.22-26, 2016

Tonyali, O. Et Al. (2016) . "Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab." BREAST , vol.25, pp.22-26.

@article{article, author={Onder Tonyali Et Al. }, title={Risk factors for brain metastasis as a first site of disease recurrence in patients with HER2 positive early stage breast cancer treated with adjuvant trastuzumab}, journal={BREAST}, year=2016, pages={22-26} }